Short Interest in NewGenIvf Group Limited (NASDAQ:NIVF) Declines By 89.7%

NewGenIvf Group Limited (NASDAQ:NIVF) was the recipient of a significant drop in short interest during the month of July. As of July 15th, there was short interest totaling 67,374 shares, a drop of 89.7% from the June 30th total of 654,534 shares. Approximately 2.9% of the company’s stock are sold short. Based on an average daily volume of 485,212 shares, the short-interest ratio is currently 0.1 days.

NewGenIvf Group Trading Down 9.8%

NewGenIvf Group stock traded down $0.12 during mid-day trading on Friday, hitting $1.10. The company had a trading volume of 176,396 shares, compared to its average volume of 336,639. NewGenIvf Group has a 12 month low of $1.10 and a 12 month high of $568.53. The stock’s 50 day moving average price is $1.91 and its two-hundred day moving average price is $6.94. The company has a current ratio of 3.12, a quick ratio of 2.98 and a debt-to-equity ratio of 0.16.

NewGenIvf Group (NASDAQ:NIVF) last announced its quarterly earnings data on Tuesday, March 31st. The company reported ($861.72) EPS for the quarter. The firm had revenue of $1.42 million during the quarter. Research analysts expect that NewGenIvf Group will post 14.22 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research firms recently weighed in on NIVF. Wall Street Zen raised NewGenIvf Group to a “hold” rating in a report on Saturday, July 4th. Weiss Ratings reiterated a “sell (d)” rating on shares of NewGenIvf Group in a report on Monday, April 27th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, NewGenIvf Group has an average rating of “Sell”.

Insiders Place Their Bets

In related news, major shareholder Financial Lp Hrt bought 45,847 shares of the business’s stock in a transaction on Friday, May 22nd. The shares were bought at an average cost of $2.97 per share, for a total transaction of $136,165.59. Following the completion of the acquisition, the insider directly owned 37,295 shares in the company, valued at approximately $110,766.15. This represents a -536.10% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 31.80% of the stock is currently owned by company insiders.

NewGenIvf Group Company Profile

NewGenIVF Group Inc, trading on NASDAQ under the symbol NIVF, is an integrated provider of reproductive medicine services in the People’s Republic of China. The company operates a network of fertility clinics across major Chinese cities, delivering comprehensive infertility diagnosis and treatment to patients and couples. Its facilities are equipped with modern laboratories and surgical suites designed for assisted reproductive procedures.

NewGenIVF’s service offerings encompass a wide range of assisted reproductive technologies (ART), including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and fertility preservation through ovarian tissue and gamete cryopreservation.